Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM-101 in Acute Inner Ear Tinnitus
NCT01270282Phase 2Completed
- Sponsor
- Altamira Therapeutics
- Start
- Feb 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of gacyclidine in tinnitus, sponsored by Altamira Therapeutics. Started Feb 2011; status: completed.
02
Drugs
gacyclidine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT01270282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270282.